FYN and Parkinson disease: Previously, Dunah et al. (2004) reported that Fyn null-mice were resistant to 6-hydroxydopamine-induced striatal lesions, necessitating a systematic investigation and characterization of the mechanistic underpinnings of Fyn in PD.